Abstract:Background Individuals with Parkinson's Disease (PD) commonly have reduced exercise capacity, which impacts autonomy and quality of life. The 6-minute walk test (6MWT) has adequate measurement properties to assess exercise capacity in this population. However, these individuals have a reduced fatigue threshold, which may make it difficult to apply prolonged exercise tests. Two-minute walk test (2MWT) is a potential alternative to optimize the measurement of this outcome. Objectives To assess the t validity of the 2MWT for assessing exercise capacity in individuals with PD. Methods A methodological study was developed. People with idiopathic PD, age ≥ 50 years, medically stable for at least 6 months, classified between the stages 1-3 of the modified Hoehn and Yahr scale were included. Individuals were instructed to walk the longest possible distance in six minutes in a 30-meter corridor. Standardized stimuli were provided every minute of the test. In the second and sixth minutes, the distances covered were recorded. Two tests were performed with an interval of 30 minutes or until hemodynamic stabilization. The best total distance covered (in meters) was used in the analyses. Descriptive statistics was used to characterize the sample. Pearson's Correlation Coefficient was used to investigate the correlation between the tests (6MWT and 2MWT). Regression analysis was used to develop an equation to predict the distance covered in the 6MWT based on the 2MWT. The intraclass correlation coefficient (ICC) was used to assess the validity of the equation. The magnitude of the correlation was classified as follows: very low≤ 0.25; low=0.26-0.49; moderate=0.50-0.69; high = 0.70-0.89; and very high = 0.90-1.00. The significance level was α=0.05. Results Forty-six individuals, 32 males (69.6%), mean age 66.93±8.34 years, and mean disease duration 8.5±5.96 years were included. Most were classified at stage 2.0 (54 .3%) and 3.0 (17.4%) on the modified Hoehn & Yahr Scale. Significant, and very high magnitude correlation between the distance covered in the tests was found (6MWT and 2MWT) (r=0.95; p < 0.001). The equation developed to estimate the distance covered in the 6MWT explained 91% of the 6MWT variability: 6MWTdistance=46,31+(2,40x2MWTdistance). Significant, and very high magnitude agreement between the distance covered in the 6MWT and predicted by the equation was found (ICC= 0.90; p < 0.001). Conclusion Preliminary results indicate adequate validity of the 2MWT to assess exercise capacity in individuals with PD. Furthermore, the developed equation was adequate to predict the distance covered in the 6MWT based upon in the distance covered in the 2MWT. However, the study must be completed to ensure the results. Implications The 2MWT has potential to assess exercise capacity in individuals with PD, and the developed equation can estimate the distance covered in the 6MWT. This can optimize the measurement of this result, making the measurement feasible.

Psychometric properties of the 1-sit-to-stand test in pulmonary hypertension

Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST)

The one-minute sit-to-stand test: A practical tool for assessing functional exercise capacity in patients with COPD in routine clinical practice

The 1-minute sit-to-stand test to evaluate fibrotic interstitial lung disease

Clinical Significance of 30-Second Sit-to-Stand Test in Patients with Idiopathic Pulmonary Fibrosis

Short- and long-term reliability of the 1-minute sit-to-stand test in patients with COPD.

Measurement properties of the incremental step test for people with chronic obstructive pulmonary disease: a cross-sectional study

The association between the one-minute sit-to-stand test and physical activity in patients with COPD following pulmonary rehabilitation

Reliability and validity of sit-to-stand test protocols in patients with coronary artery disease

A Comparative Study Of The Five-Repetition Sit-To-Stand Test And The 30-Second Sit-To-Stand Test To Assess Exercise Tolerance In Copd Patients

Functional capacity using sit-to-stand tests in people with chronic obstructive pulmonary disease and its relationship with disease severity-a cross-sectional study with matched controls

The five-repetition sit-to-stand test as a functional outcome measure in COPD

Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

Cardiorespiratory response of the incremental step test in people with chronic obstructive pulmonary disease

Reference values for the 1-minute sit-to-stand and 5 times sit-to-stand tests to assess functional capacity: a cross-sectional study

Cut-off values of one-minute sit-to-stand test for determining physical performance in mild-post-COVID-19 individuals

Validation of the two-minute step test in obese with comorbibities and morbidly obese patients

VALIDITY OF THE 2-MINUTE WALK TEST TO ASSESS EXERCISE CAPACITY IN INDIVIDUALS WITH PARKINSON DISEASE

Which sit-to-stand test best differentiates functional capacity in older people?

App-Based Versus Standard Six-Minute Walk Test in Pulmonary Hypertension: Mixed Methods Study

Usefulness of the 6-minute walk test vs cardiopulmonary exercise test for exercise prescription in coronary artery disease patients going into a phase III cardiac rehabilitation program